BE827804A - Methode et compositions pour la mise en oeuvre pharmaceutique des prostaglandines - Google Patents
Methode et compositions pour la mise en oeuvre pharmaceutique des prostaglandinesInfo
- Publication number
- BE827804A BE827804A BE155295A BE155295A BE827804A BE 827804 A BE827804 A BE 827804A BE 155295 A BE155295 A BE 155295A BE 155295 A BE155295 A BE 155295A BE 827804 A BE827804 A BE 827804A
- Authority
- BE
- Belgium
- Prior art keywords
- prostaglandins
- compositions
- pharmaceutical use
- pharmaceutical
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 title 1
- 150000003180 prostaglandins Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4015—Esters of acyclic unsaturated acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4018—Esters of cycloaliphatic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB16242/74A GB1484591A (en) | 1974-04-11 | 1974-04-11 | Prostaglandin compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
BE827804A true BE827804A (fr) | 1975-10-10 |
Family
ID=10073769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE155295A BE827804A (fr) | 1974-04-11 | 1975-04-10 | Methode et compositions pour la mise en oeuvre pharmaceutique des prostaglandines |
Country Status (12)
Country | Link |
---|---|
US (1) | US3978229A (fr) |
AU (1) | AU497401B2 (fr) |
BE (1) | BE827804A (fr) |
CA (1) | CA1049410A (fr) |
DK (1) | DK137977B (fr) |
FR (1) | FR2267091B1 (fr) |
GB (1) | GB1484591A (fr) |
IE (1) | IE40977B1 (fr) |
LU (1) | LU72258A1 (fr) |
NL (1) | NL7504303A (fr) |
SE (1) | SE7504150L (fr) |
ZA (1) | ZA752304B (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4152524A (en) * | 1974-04-02 | 1979-05-01 | American Cyanamid Company | Cycloalkyl and cycloalkenyl prostaglandin congeners |
GB1494321A (en) * | 1974-08-08 | 1977-12-07 | Ici Ltd | Prostanoic acid derivatives |
DE2524955C3 (de) * | 1975-06-05 | 1981-12-03 | Hoechst Ag, 6000 Frankfurt | Neue Thienyl-Prostaglandine und Verfahren zu ihrer Herstellung |
US4028396A (en) * | 1975-07-02 | 1977-06-07 | American Cyanamid Company | 16,16-Spirocycloalkyl prostaglandin derivatives |
JPS5395958A (en) * | 1977-01-31 | 1978-08-22 | Ono Pharmaceut Co Ltd | Prostaglandin analogues and process for their preparation |
US4123463A (en) * | 1978-03-21 | 1978-10-31 | The Upjohn Company | 2-Decarboxy-2-alkylketone prostaglandins |
US4289785A (en) * | 1980-08-06 | 1981-09-15 | The Upjohn Company | Method and compositions involving prostaglandins |
GB8324004D0 (en) * | 1983-09-07 | 1983-10-12 | Erba Farmitalia | 16-fluoro-16 17-didehydro prostanoids |
US5185374A (en) * | 1988-05-11 | 1993-02-09 | K.K. Ueno Seiyaku Oyo Kenkyujo | Use of 15-ketoprostaglandin E or F compounds for uterine contraction |
GB0112699D0 (en) * | 2001-05-24 | 2001-07-18 | Resolution Chemicals Ltd | Process for the preparation of prostglandins and analogues thereof |
CN101948484B (zh) * | 2010-09-19 | 2012-07-11 | 武汉武药科技有限公司 | 一种曲伏前列素中间体的制备方法 |
-
1974
- 1974-04-11 GB GB16242/74A patent/GB1484591A/en not_active Expired
-
1975
- 1975-04-08 US US05/566,146 patent/US3978229A/en not_active Expired - Lifetime
- 1975-04-09 FR FR7511037A patent/FR2267091B1/fr not_active Expired
- 1975-04-10 NL NL7504303A patent/NL7504303A/xx not_active Application Discontinuation
- 1975-04-10 LU LU72258A patent/LU72258A1/xx unknown
- 1975-04-10 CA CA224,288A patent/CA1049410A/fr not_active Expired
- 1975-04-10 IE IE818/75A patent/IE40977B1/xx unknown
- 1975-04-10 BE BE155295A patent/BE827804A/fr unknown
- 1975-04-10 AU AU80038/75A patent/AU497401B2/en not_active Expired
- 1975-04-10 DK DK154975AA patent/DK137977B/da not_active IP Right Cessation
- 1975-04-10 ZA ZA00752304A patent/ZA752304B/xx unknown
- 1975-04-10 SE SE7504150A patent/SE7504150L/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DK154975A (fr) | 1975-10-12 |
DK137977B (da) | 1978-06-19 |
AU497401B2 (en) | 1978-12-14 |
FR2267091B1 (fr) | 1981-03-27 |
IE40977L (en) | 1975-10-11 |
AU8003875A (en) | 1976-10-14 |
ZA752304B (en) | 1976-03-31 |
DK137977C (fr) | 1978-11-13 |
LU72258A1 (fr) | 1976-03-17 |
CA1049410A (fr) | 1979-02-27 |
IE40977B1 (en) | 1979-09-26 |
GB1484591A (en) | 1977-09-01 |
FR2267091A1 (fr) | 1975-11-07 |
SE7504150L (sv) | 1975-10-13 |
US3978229A (en) | 1976-08-31 |
NL7504303A (nl) | 1975-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG23212A3 (bg) | Метод за получаване на арилоксифенилпропиламини | |
BE826022A (fr) | Capsule pour bouteille | |
FR2295928A1 (fr) | Compositions et procedes pour la production de ciments durcis | |
IT1028449B (it) | Amalgama per odontoiatria e metodo per la preparazione dello stesso | |
RO68142A (fr) | Procede pour la preparation des 4-phenylpyperidines | |
BE829573A (fr) | Nouveaux produits opacifiants pour la radiographie | |
BE827804A (fr) | Methode et compositions pour la mise en oeuvre pharmaceutique des prostaglandines | |
TR19139A (tr) | Laktatdehidrojenazenin izoenzimlerinin hepbirden tesbitine mahsus usul | |
CH533460A (fr) | Procédé pour la mise en émulsion de produits pétroliers, composition pour la mise en oeuvre du procédé, émulsion obtenue, et utilisation de l'émulsion | |
FR2287415A1 (fr) | Procede pour la preparation de gaz reducteurs | |
BG26521A3 (bg) | Метод за получаване на 1-(заместени бензоил)-3-(заместени пиразинил)- карбамиди | |
RO70894A (fr) | Procede pour la preparation des phenylalkylamines | |
FR2298934A1 (fr) | Methode pour cultiv | |
IT1056281B (it) | Apparecchio per la produzione di pezzi colati | |
BE831234A (fr) | Procede de dosage radio-immunologique pour la mise en evidence des anticorps de neisseria gonorrheae | |
RO66914A (fr) | Procede pour la preparation des pyrido-benzodiazepinones | |
BG24539A3 (bg) | Метод за получаване на 1-етил- за- субституирани - фенил - декахидроизохинолини | |
IT1016860B (it) | Procedimento ed apparecchio per la colata particolarmente di acciaio | |
IT1051011B (it) | Apparato e metodo per la fabbricazione di tubi per colata | |
RO63021A (fr) | Procede pour la preparation des 3-fluorcephalosporines | |
SE430895B (sv) | Forfarande for kontinuerlig framstellning av cellulosaglykolat | |
IT1047960B (it) | Procedimento per la colata di lingotti | |
FR2279207A1 (fr) | Installation pour l'irradiation des produits fluides | |
RO68749A (fr) | Procede pour la preparation des 2-amidoimidazoles | |
RO66020A (fr) | Procede pour la preparation des 3-pyperazinoisoquinolines |